Phase 1:
Model preparation and selection of representative products: Collating client product data, developing draft models for approval, physical preparation of each model and placebo.
Phase 2:
Method feasibility: RSSL’s in-house methods used to assess each active and placebo for sensitivity, specificity, recovery, and linearity. Those developed for vitamins A, E, D, B3, B5 and B6 were deemed suitable. However, vitamins B1, B2, B7 and B12 in capsules required further method development due to low recoveries, while B9 showed a closely eluting peak which caused concern.
Phase 3:
Method optimisation/development: Remedial actions taken to address identified issues. This included optimising extraction for vitamins B1, B7 and B12, as well as optimising chromatographic conditions for B9 to remove the impact of the closely eluting interference peak.
Phase 4:
Method validation: Performed according to the following parameters: specificity, linearity, accuracy (recovery), method precision (repeatability), limit of quantification and detection (LoQ and LoD).